SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-014359
Filing Date
2023-05-15
Accepted
2023-05-15 08:22:23
Documents
54
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dffn20230331_10q.htm   iXBRL 10-Q 610874
2 EXHIBIT 31.1 ex_518005.htm EX-31.1 9060
3 EXHIBIT 31.2 ex_518006.htm EX-31.2 8934
4 EXHIBIT 32.1 ex_518007.htm EX-32.1 4777
5 EXHIBIT 32.2 ex_518008.htm EX-32.2 5194
11 dffn20230331_10qimg001.jpg GRAPHIC 3726
  Complete submission text file 0001437749-23-014359.txt   3510807

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dffn-20230331.xsd EX-101.SCH 34782
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dffn-20230331_def.xml EX-101.DEF 238634
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE dffn-20230331_lab.xml EX-101.LAB 202607
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dffn-20230331_pre.xml EX-101.PRE 259594
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dffn-20230331_cal.xml EX-101.CAL 19394
48 EXTRACTED XBRL INSTANCE DOCUMENT dffn20230331_10q_htm.xml XML 502578
Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37942 | Film No.: 23918589
SIC: 2834 Pharmaceutical Preparations